Twist Bioscience Corp SEC filings TWST

Twist Bioscience Corp has 1,007 filings in SEC EDGAR's recent list, going back to Oct 4, 2022. Its latest annual report, Form ARS, was filed on Jan 6, 2026 for the period ended Sep 30, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 3, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 19, 2026 (other events). The company's fiscal year ends on September 30.

Form Description Filed Period
424B7 Filing Aug 19, 2026 —
424B5 Prospectus supplement Aug 5, 2026 —
424B5 Prospectus supplement Aug 4, 2026 —
S-3ASR Automatic shelf registration Jun 18, 2026 —
424B7 Filing Feb 17, 2026 —
S-8 Employee stock plan registration Feb 12, 2025 —
S-8 Employee stock plan registration Nov 18, 2024 —
S-8 Employee stock plan registration Nov 21, 2023 —
S-8 Employee stock plan registration Aug 25, 2023 —
S-3ASR Automatic shelf registration Jun 5, 2023 —
S-8 Employee stock plan registration Nov 28, 2022 —

Showing 11 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
TWST (Nasdaq)
Fiscal year ends
September 30
Incorporated in
DE
Headquarters
South San Francisco, CA
SEC filer status
Large accelerated filer
SEC CIK
1581280

Other Biological Products, (No Diagnostic Substances) companies

All 182 Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.